Dr Robert Hunter Wineland, DO | |
27th Somg Flight And Operational Medicine, Cannon Afb, NM 88103 | |
(804) 577-7363 | |
Not Available |
Full Name | Dr Robert Hunter Wineland |
---|---|
Gender | Male |
Speciality | Military Health Care Provider |
Location | 27th Somg Flight And Operational Medicine, Cannon Afb, New Mexico |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184299810 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 83594 (South Carolina) | Secondary |
171000000X | Military Health Care Provider | 2677 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robert Hunter Wineland, DO 27th Somg Flight And Operational Medicine, Cannon Afb, NM 88103 Ph: (804) 577-7363 | Dr Robert Hunter Wineland, DO 27th Somg Flight And Operational Medicine, Cannon Afb, NM 88103 Ph: (804) 577-7363 |
News Archive
The number of infants who develop flat head syndrome -; deformational plagiocephaly – has increased significantly since the start of the Back to Sleep campaign to combat Sudden Infant Death Syndrome (SIDS) in the 1990s.
Finnish mobile wellness technology company PulseOn has closed a €1m seed investment round to finalize and launch its ground-breaking innovation in optical heart rate monitoring.
A new, large-scale study has identified six new genetic variants associated with habitual coffee drinking. The genome-wide meta-analysis, led by Harvard School of Public Health and Brigham and Women's Hospital researchers, helps explain why a given amount of coffee or caffeine has different effects on different people and provides a genetic basis for future research exploring the links between coffee and health.
Six new grants from the National Institutes of Health will support researchers to develop new computational approaches for searching among millions of genomic variants to find those that make a difference in disease susceptibility or in other traits.
SRU Biosystems, a leader in highly sensitive label-free detection technologies, today announced the issuance of a Notice of Allowance from the US Patent Office for claims on a fundamental patent application, US Patent Application No. 11/635,934, for performing cellular assays on optical label-free biosensors.
› Verified 9 days ago